TLR4 and hepatocellular carcinoma: Further research is required to fully understand the role of TLR4 signaling on HCC immunotherapy in order to accurately manipulate the receptor into either enhancing or inhibiting its signal within the TME, which would lead to the development of optimal and individualized treatment strategies for patients with HCC.